References
- Noergaard-Pedersen B, Larsen Olesen S, Arends J, Svenstrup B, Tabor A. Maternal serum markers in screening for Down syndrome. Clinical Genetics 1990; 37: 35–43
- Puhakainen E, Ryynänen M. The use of a sensitive alpha-fetoprotein method and low maternal serum value in the screening of trisomies during the second trimester of pregnancy. Biochimica clinica 1989; 13(Suppl. 1/8)329
- Ryynänen M. “Screening of fetal malformations with the measurement of alpha-fetoprotein of maternal serum in Eastern Finland”. Publications of the University of Kuopio, Medicine, 1–81, Original reports 4/1981 Finland
- Seppälä M, Aula P, Rapola J., Karjalainen O, Huttunen N-P., Ruoslahti E. Congenital nephrotic syndrome: prenatal diagnosis and genetic counselling by estimation of amniotic-fluid and maternal serum alpha-fetoprotein. Lancet 1976; 2: 123–125
- Wald N J, Cuckle H S, Densem J W, Nanchahal K, Royston P, Chard T, Haddow J E, Knight G J, Palomaki G E, Canick J. A. Maternal serum screening for Down's syndrome in early pregnancy. Brit Med J 1988; 297: 883–887